Page last updated: 2024-12-10

1-palmitoyl-2-oleoyl-sn-glycerol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1-Palmitoyl-2-oleoyl-sn-glycerol: A Key Player in Lipid Research

1-Palmitoyl-2-oleoyl-sn-glycerol (POPG) is a **phospholipid**, specifically a **phosphatidylglycerol (PG)**, which plays a crucial role in various biological processes. It's named for its constituent parts:

* **Palmitoyl:** A saturated fatty acid with 16 carbon atoms.
* **Oleoyl:** An unsaturated fatty acid with 18 carbon atoms and one double bond.
* **sn-glycerol:** A glycerol molecule with specific numbering of its carbon atoms, indicating the positions of the fatty acid chains.

### Importance in Research

POPG is important for research due to its diverse functions and involvement in various cellular processes, including:

* **Membrane Structure:** POPG is a major component of **bacterial cell membranes**, and it plays a vital role in maintaining the fluidity and stability of the membrane. This makes it a crucial target for **antibiotic development** and understanding **bacterial pathogenesis**.
* **Lipid Signaling:** POPG is involved in various **lipid signaling pathways**, regulating processes such as **cell growth, differentiation, and apoptosis**. This makes it a key player in **cancer research**, exploring its potential as a therapeutic target.
* **Liposome Formation:** POPG is commonly used in **liposome research** due to its ability to form stable liposomes, making it a valuable tool for drug delivery, gene therapy, and vaccine development.
* **Model System:** POPG is widely used as a **model system for studying membrane properties** due to its well-characterized structure and availability. Researchers can utilize this model to understand how lipids influence membrane structure, fluidity, and interactions with proteins.

### Applications in Research

POPG finds applications in various research fields, including:

* **Drug Discovery and Development:** Targeting POPG in bacterial membranes can lead to the development of new antibiotics. Its involvement in lipid signaling pathways makes it a potential target for anti-cancer drugs.
* **Biotechnology:** POPG is crucial for the development of **gene delivery systems** and **therapeutic liposomes** due to its ability to form stable and functional liposomes.
* **Membrane Biology:** POPG serves as a valuable tool for understanding the **physical and chemical properties of membranes**, including their fluidity, stability, and interactions with other molecules.

### Conclusion

1-Palmitoyl-2-oleoyl-sn-glycerol is a vital phospholipid with diverse biological functions. Its importance in bacterial membranes, lipid signaling, liposome formation, and as a model system makes it a crucial component in various research areas, particularly those focused on drug development, biotechnology, and membrane biology.

1-palmitoyl-2-oleoyl-sn-glycerol: a long-chain diacylglycerol; RN given refers to compound with no isomeric designation of the glycerol C2 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1-palmitoyl-2-oleoyl-sn-glycerol : A 1,2-diacyl-sn-glycerol with palmitoyl as the 1-acyl group and oleoyl as the 2-acyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5282283
CHEBI ID75466
SCHEMBL ID2899966
MeSH IDM0223269

Synonyms (36)

Synonym
(s)-1-hydroxy-3-(palmitoyloxy)propan-2-yl oleate
dg(16:0/18:1(9z)/0:0)
dg(16:0/18:1/0:0)
LMGL02010006
1-hexadecanoyl-2-(9z-octadecenoyl)-sn-glycerol
1-palmitoyl-2-oleoyl-sn-glycerol
[(2s)-1-hexadecanoyloxy-3-hydroxypropan-2-yl] (z)-octadec-9-enoate
dg (16:0/18:1(n-9)/0:0)
(2s)-1-(hexadecanoyloxy)-3-hydroxypropan-2-yl (9z)-octadec-9-enoate
CHEBI:75466
SCHEMBL2899966
dg 34:1
olein, 1-palmito-2-, l-
FU2FI047ZI ,
palmitin, 2-oleo-1-, l-
29541-66-0
9-octadecenoic acid (9z)-, (1s)-1-(hydroxymethyl)-2-((1-oxohexadecyl)oxy)ethyl ester
1-palmitoyl-2-oleoylglycerol, (s)-
16:0-18:1 dg
YEJYLHKQOBOSCP-OZKTZCCCSA-N
dag(16:0/18:1n9)
diacylglycerol(16:0/18:1n9)
diacylglycerol(16:0/18:1w9)
dag(16:0/18:1w9)
dg(16:0/18:1w9)
dg(16:0/18:1n9)
HY-134200
J-018286
unii-fu2fi047zi
Q27145332
(s)-1-palmitoyl-2-oleoylglycerol
1-palmitin-2-olein
MS-30574
STARBLD0002430
CS-0138885
PD193042
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
1,2-diacyl-sn-glycerol
1-palmitoyl-2-oleoylglycerolA 1,2-diglyceride with palmitoyl and oleoyl as the two acyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (45)

PathwayProteinsCompounds
Phosphatidylinositol Phosphate Metabolism2213
Joubert Syndrome2213
phospholipid biosynthesis CL(16:0/18:1(9Z)/16:0/18:1(9Z))1124
Triacylglycerol Degradation TG(16:0/18:1(9Z)/16:0)512
Triacylglycerol Degradation TG(16:0/18:1(9Z)/18:0)513
Triacylglycerol Degradation TG(16:0/18:1(9Z)/18:1(9Z))512
Triacylglycerol Degradation TG(16:0/18:1(9Z)/18:1(11Z))513
Triacylglycerol Degradation TG(16:0/18:1(9Z)/18:2(9Z,12Z))513
Triacylglycerol Degradation TG(16:0/18:1(9Z)/18:3(6Z,9Z,12Z))513
Triacylglycerol Degradation TG(16:0/18:1(9Z)/18:3(9Z,12Z,15Z))513
Triacylglycerol Degradation TG(16:0/18:1(9Z)/20:0)513
Triacylglycerol Degradation TG(16:0/18:1(9Z)/20:1(11Z))513
Triacylglycerol Degradation TG(16:0/18:1(9Z)/20:1(13Z))512
Triacylglycerol Degradation TG(16:0/18:1(9Z)/22:0)513
Triacylglycerol Degradation TG(16:0/18:1(9Z)/22:1(13Z))513
Phosphatidylcholine Biosynthesis PC(16:0/18:1(9Z))620
Phosphatidylethanolamine Biosynthesis PE(16:0/18:1(9Z))516
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:0)515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:1(9Z))514
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:1(11Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:2(9Z,12Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/16:0)514
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:0)515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:0)515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/24:0)515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/14:1(9Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/16:1(9Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:1(11Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:3(5Z,8Z,11Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:1(13Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/24:1(15Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:3(6Z,9Z,12Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:2(13Z,16Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:3(9Z,12Z,15Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))515
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:2(11Z,14Z))514
De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:3(8Z,11Z,14Z))514
Phosphatidylcholine/Phosphatidylethanolamine Biosynthesis PC(16:0/18:1(9Z)) | PE(16:0/18:1(9Z))617

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (57.14)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.24 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index27.81 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]